FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India (Q47577131)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2012

Language	Label	Description	Also known as
English	FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India	scientific article published on 26 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

1 reference

based on heuristic

inferred from title

author name string

Kanjaksha Ghosh

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Suchitra Swaminathan

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Manisha Madkaikar

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Maya Gupta

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Lily Kerketta

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Baburao Vundinti

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

publication date

26 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

91

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

1703-1712

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Adult acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Clinical importance of cytogenetics in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Realistic pathologic classification of acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Analysis of NPM1 gene mutations in Chinese adults with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Genetics of myeloid malignancies: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1509-Z

21 January 2018

Identifiers

10.1007/S00277-012-1509-Z

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22733614

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47577131&oldid=2160582270"